Ratio Review: Analyzing Adaptive Biotechnologies Corp (ADPT)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $6.29 in the prior trading day, Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $6.11, down -2.86%. In other words, the price has decreased by -$2.86 from its previous closing price. On the day, 0.84 million shares were traded. ADPT stock price reached its highest trading level at $6.23 during the session, while it also had its lowest trading level at $5.92.

Ratios:

Our goal is to gain a better understanding of ADPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.96.

On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.

Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when PISKEL KYLE sold 248 shares for $4.98 per share. The transaction valued at 1,235 led to the insider holds 154,330 shares of the business.

Taylor Stacy L sold 26,922 shares of ADPT for $121,079 on Aug 22 ’24. The SVP and General Counsel now owns 139,365 shares after completing the transaction at $4.50 per share. On Aug 22 ’24, another insider, STACY L TAYLOR, who serves as the Officer of the company, bought 26,922 shares for $4.50 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 901707776 and an Enterprise Value of 882707648. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.97 while its Price-to-Book (P/B) ratio in mrq is 4.03. Its current Enterprise Value per Revenue stands at 4.979 whereas that against EBITDA is -6.007.

Stock Price History:

Over the past 52 weeks, ADPT has reached a high of $7.07, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 8.62%, while the 200-Day Moving Average is calculated to be 42.52%.

Shares Statistics:

The stock has traded on average 1.17M shares per day over the past 3-months and 1086590 shares per day over the last 10 days, according to various share statistics. A total of 147.56M shares are outstanding, with a floating share count of 142.73M. Insiders hold about 3.28% of the company’s shares, while institutions hold 92.21% stake in the company. Shares short for ADPT as of 1734048000 were 9030599 with a Short Ratio of 7.74, compared to 1731628800 on 8203880. Therefore, it implies a Short% of Shares Outstanding of 9030599 and a Short% of Float of 7.8600004000000006.

Most Popular